Cardiovascular Disease News and Research RSS Feed - Cardiovascular Disease News and Research

According to the Centers for Disease Control and Prevention, about 700,000 people die annually of cardiovascular disease. Cardiovascular disease involves the heart and vessels and is the number one killer in the U.S. accounting for nearly 30-percent of all deaths. Cardiovascular disease has a number of forms but the most common are myocardial infarction and angina pectoris which affect the heart itself. There are well known environmental risk factors associated with cardiovascular disease such as smoking, diet, inactivity and increased alcohol use. Heredity also plays a factor in cardiovascular disease since other risk factors like high blood pressure and high LDL cholesterol tend to run in families. Cardiovascular disease can be reduced by controlling environmental factors and understanding the genetic factors that put people at greater risk for heart disease.
Decaffeinated coffee may benefit liver health

Decaffeinated coffee may benefit liver health

Researchers from the National Cancer Institute report that decaffeinated coffee drinking may benefit liver health. Results of the study published in Hepatology, a journal of the American Association for the Study of Liver Diseases, show that higher coffee consumption, regardless of caffeine content, was linked to lower levels of abnormal liver enzymes. This suggests that chemical compounds in coffee other than caffeine may help protect the liver. [More]
Overuse of cardiac stress testing with imaging increases healthcare costs

Overuse of cardiac stress testing with imaging increases healthcare costs

In a new study recently published in the Annals of Internal Medicine, researchers at NYU Langone Medical Center concluded that overuse of cardiac stress testing with imaging has led to rising healthcare costs and unnecessary radiation exposure to patients. [More]
New study finds that not having close access to healthy foods can deter even motivated dieters

New study finds that not having close access to healthy foods can deter even motivated dieters

You're obese, at risk for diabetes and cardiovascular disease, and so motivated to improve your diet that you've enrolled in an intensive behavioral program. But if you need to travel more than a short distance to a store that offers a good selection of healthy food, your success may be limited. [More]
Case Western Reserve researcher lands Director's New Innovator Awards from NIH

Case Western Reserve researcher lands Director's New Innovator Awards from NIH

For the second consecutive year, a Case Western Reserve University School of Medicine researcher has landed one of the year's much-coveted Director's New Innovator Awards from the National Institutes of Health. Principal investigator Rong Xu, PhD, assistant professor of medical informatics, will receive $2,377,000 for five years, starting immediately, to initiate computational analysis of thousands of drugs and their effects. [More]
Leading experts urge Canadian health-care providers to improve care for people living with SCI

Leading experts urge Canadian health-care providers to improve care for people living with SCI

Leading Canadian spinal cord injury (SCI) experts have launched the unprecedented Spinal Cord Injury: A Manifesto for Change—a call to action and a plea for Canadian health-care providers and stakeholders to work in coordination to improve care and the health of people living with SCI in Canada. [More]
Genetic susceptibility to psychosocial stress can increase risk of cardiovascular disease

Genetic susceptibility to psychosocial stress can increase risk of cardiovascular disease

A new genetic finding from Duke Medicine suggests that some people who are prone to hostility, anxiety and depression might also be hard-wired to gain weight when exposed to chronic stress, leading to diabetes and heart disease. [More]
Mymetics' innovative HIV vaccine candidate to enter new preclinical trial

Mymetics' innovative HIV vaccine candidate to enter new preclinical trial

Mymetics Corporation, a pioneer in the research and development of virosome-based vaccines to prevent transmission of human infectious diseases across mucosal membranes, announced today that its innovative HIV vaccine candidate will enter a new preclinical trial to confirm excellent results obtained in a previous trial. [More]
Study: Dietary polyunsaturated fatty acids may reduce coronary heart disease risk

Study: Dietary polyunsaturated fatty acids may reduce coronary heart disease risk

A recent study completed at the University of Eastern Finland shows that dietary polyunsaturated fatty acids may reduce the risk of coronary heart disease. The sources of polyunsaturated fatty acids include fish, vegetable oils, and nuts. [More]
Three institutions collaborate to study genetics of bipolar disorder, schizophrenia

Three institutions collaborate to study genetics of bipolar disorder, schizophrenia

Researchers at the University of Michigan School of Public Health and Medical School and collaborators at two other institutions will undertake the largest whole genome sequencing study funded to date, as they seek to better understand bipolar disorder and schizophrenia. [More]
Phase 3 COU-AA-302 results show ZYTIGA plus prednisone prolongs overall survival in men with chemotherapy-naive mCRPC

Phase 3 COU-AA-302 results show ZYTIGA plus prednisone prolongs overall survival in men with chemotherapy-naive mCRPC

A final analysis of the Phase 3 COU-AA-302 trial presented today at the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid, Spain showed that ZYTIGA® (abiraterone acetate) plus prednisone significantly prolonged overall survival (OS), compared to an active control of placebo plus prednisone, in men with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC). [More]
Galmed Pharmaceuticals purchases EndoPAT devices, accessories from Itamar Medical

Galmed Pharmaceuticals purchases EndoPAT devices, accessories from Itamar Medical

Galmed Pharmaceuticals Ltd. ("Galmed"), a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral medication for the treatment of liver diseases and cholesterol gallstones, announced today that it purchased 60 EndoPAT™ devices and accessories from Itamar Medical Ltd. [More]
CVRx Barostim neo System receives CE Mark approval from NSAI for treatment of heart failure

CVRx Barostim neo System receives CE Mark approval from NSAI for treatment of heart failure

CVRx, Inc., a private medical device company, announced today it received CE Mark approval from the National Standards Authority of Ireland of the Barostim neo System for the treatment of heart failure. [More]
Health advocates call for the United Nations to support efforts to curb heart disease, stroke

Health advocates call for the United Nations to support efforts to curb heart disease, stroke

Heart disease and stroke contribute to 30 percent of global deaths, more than all infectious and parasitic diseases combined, and 11 cardiovascular organizations are calling for the United Nations to address prevention of heart disease and other non-communicable diseases. [More]
Study finds that only half of U.S. adults screened for diabetes in last three years

Study finds that only half of U.S. adults screened for diabetes in last three years

A new cross-sectional study in American Journal of Preventive Medicine finds that only half of adults in the U.S. were screened for diabetes within the last three years, less than what is recommended by the American Diabetes Association. [More]
Study on widespread vitamin D deficiency among patients who undergo thyroidectomy

Study on widespread vitamin D deficiency among patients who undergo thyroidectomy

A new study from researchers at Henry Ford Hospital in Detroit finds widespread vitamin D deficiency among patients who undergo a thyroidectomy, potentially putting them at greater risk for developing dangerously low blood calcium levels after surgery. [More]
Weight cycling linked to relapse-prone bipolar course

Weight cycling linked to relapse-prone bipolar course

Patients with bipolar disorder are more likely than healthy controls to have a history of weight cycling, which in turn is associated with an increased likelihood of manic and depressive episodes, researchers report. [More]
MediValve successfully completes post-market clinical evaluation of acWire Guidewire

MediValve successfully completes post-market clinical evaluation of acWire Guidewire

MediValve, Ltd., a Trendlines portfolio company, today announced that it has successfully completed the first two cases of post-market clinical evaluation of its acWire Guidewire. [More]
Obesity, other cardiovascular issues to be the focus of Brazilian Congress of Cardiology

Obesity, other cardiovascular issues to be the focus of Brazilian Congress of Cardiology

More than 4,000 extra wide seats were made to accommodate Brazil's increasing obese population during the World Cup this year. Obesity affects nearly 20 percent of the population in Brazil and is currently classified as a disability. This and other cardiovascular issues, such as the overuse of technology, will be the focus of the Brazilian Congress of Cardiology, a joint event with the European Society of Cardiology and the Brazilian Society of Cardiology, 26-29 September. [More]
Brandeis researchers explore relationship between weight and stress-induced inflammation

Brandeis researchers explore relationship between weight and stress-induced inflammation

If you're overweight, you may be at greater risk for stress-related diseases like type 2 diabetes, cardiovascular disease and cancer, according to a new study by Brandeis University. [More]
UC San Diego SCVC named among "100 Hospitals with Great Heart Programs"

UC San Diego SCVC named among "100 Hospitals with Great Heart Programs"

UC San Diego Sulpizio Cardiovascular Center has been named among "100 Hospitals with Great Heart Programs" by Becker's Hospital Review, a business and legal news publication for hospital and health system leadership. [More]